Moreover, lncRNA NORAD enhances pancreatic cancer metastasis through promoting epithelial–mesenchymal transition via targeting hsa-miR-125a-3p to increase RhoA expression (Li et al., 2017). Here, NORAD is linked to pancreatic neoplasm.